Top news of the week: 03.11.2020.
#BioTech #covid19 #healthcare #SCTopEmployer #ui #stocks #StayCured #StayHome
Healthcare
RT @megtirrell: What do drug companies owe the patients who participate in their clinical trials?
A great read, and a question relevant also to the #covid19 vaccine trials. https://t.co/bkOLeOVBna
OpenThe Stressful Conclusion of a Clinical Trial
Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?
Rapid response to COVID-19, diversity, and innovation #BioTech via https://t.co/2sI0UxJbpn https://t.co/rTmoMjbsJb
Open2020’s Top Employers: Rapid response to COVID-19, diversity, and innovation
Companies that made this year’s Top Employers Survey overcame challenges brought on by the COVID-19 pandemic.
Sean Bohen just wrote the handbook on how to make a quick fortune in biotech #BioTech #ui via https://t.co/2sI0UxJbpn https://t.co/irtT6Pqq5C
OpenSean Bohen just wrote the handbook on how to make a quick fortune in biotech
If you ask anyone in drug development about what motivates them — or even if you don’t — you’re going to get a regular double-barreled blast about patients and unmet medical needs if you're ...
Revive Therapeutics Expects Interim Analysis Data from Phase 3 COVID-19 Study by Year-End: https://t.co/VWaC7zPioY
$RVV.CA $RVVTF #covid19 #healthcare #stocks Revive Therapeutics Revive Therapeutics Ltd. @Revive_RVV https://t.co/gcAlyjJktZ
OpenBiotech Expects Interim Analysis Data from Phase 3 COVID-19 Study by Year-End News Update
Revive Therapeutics anticipates that more than 200 patients will complete its Phase 3 clinical trial of Bucillamine in patients with mild-moderate COVID-19 by the end of December 2020 and ...
Four Companies in Biotech Every Investor Needs to Know About
Four Companies in Biotech have captured our attention. In this report, we’ll break down whether they are good bets, or are just riding a wave of hype.
Bharat Biotech to launch India’s first coronavirus vaccine ‘Covaxin’ in Q2 2021 #BioTech via https://t.co/2sI0UxJbpn https://t.co/VbgV65Zd1X
OpenBharat Biotech to launch India’s first coronavirus vaccine ‘Covaxin’ in Q2 2021
The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
RT @staycured: Yoga & Mental Health to help Covid19 patients overcome after-effects https://t.co/IJ1x6cCoti #healthcare #StayHome #COVID19 #StayCured https://t.co/eY9Tise7Pj
OpenBharat Biotech to launch Covaxin in second quarter next year
Bharat Biotech is planning to launch its COVID-19 vaccine in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official ...
Bharat Biotech to launch Covaxin in Q2 2021 #BioTech via https://t.co/2sI0UxJbpn https://t.co/n2XqwHJamf
OpenBharat Biotech to launch Covaxin in Q2 2021
The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated ...